Synthetic platelets
AssigneeCase Western Reserve University
InventorsAnirban Sen Gupta, Christa Pawloski
Life of this patent
Estimating the term…
Abstract
A synthetic platelet including a biocompatible flexible nanoparticle, the nanoparticle having an outer surface and a plurality of site targeted peptides conjugated to the surface, the synthetic platelet also including a therapeutic agent, wherein the therapeutic agent is encapsulated by the nanoparticle, wherein the synthetic platelet adheres to the site targeted and promotes delivery of the therapeutic agent onto sites of the synthetic platelet adhesion, and wherein the therapeutic agent is released at the site targeted via a site-relevant enzyme.
Claims9
A method of treating a traumatic brain injury (TBI) in a gyrencephalic mammalian subject, the method comprising:
- administering to a gyrencephalic mammalian subject a synthetic platelet comprising a biocompatible flexible liposome nanoparticle and a therapeutic agent, wherein the therapeutic agent is encapsulated by the biocompatible flexible liposome nanoparticle, wherein the biocompatible flexible liposome nanoparticle comprises distearyl phosphatidyl ethanolamine (DSPE), distearyl phosphatidyl choline (DSPC), and cholesterol,
- wherein the synthetic platelet includes an outer surface, a plurality of peptides conjugated to the surface, the peptides including a plurality of brain injury site-targeting peptides having SEQ ID NO:
- 6 (CAQK), wherein the synthetic platelet adheres to a brain injury site and promotes delivery of the therapeutic agent onto sites of the brain injury, wherein the therapeutic agent is released at the site of brain injury via a site-relevant enzyme, and wherein the brain injury site-targeted peptides are spatially or topographically arranged on the biocompatible flexible liposome nanoparticle surface such that the brain injury site-targeted peptides do not spatially mask each other, and wherein the biocompatible flexible liposome nanoparticle shape, size and elastic modulus facilitates margination to a vascular wall and their bio-interactions upon administration to a vasculature of the subject.
A method of treating a traumatic brain injury (TBI) in a gyrencephalic mammalian subject, the method comprising:
- administering to a gyrencephalic mammalian subject a synthetic platelet comprising a biocompatible flexible liposome nanoparticle and cerebrolysin, wherein the cerebrolysin is encapsulated by the biocompatible flexible liposome nanoparticle, wherein the biocompatible flexible liposome nanoparticle comprises distearyl phosphatidyl ethanolamine (DSPE), distearyl phosphatidyl choline (DSPC), and cholesterol,
- wherein the synthetic platelet includes an outer surface, a plurality of peptides conjugated to the surface, the peptides including a plurality of brain injury site-targeting peptides having SEQ ID NO:
- 6 (CAQK), wherein the synthetic platelet adheres to a brain injury site and promotes delivery of the cerebrolysin onto sites of the brain injury, and wherein the cerebrolysin is released at the site of brain injury via a site-relevant enzyme, and wherein the brain injury site-targeted peptides are spatially or topographically arranged on the biocompatible flexible liposome nanoparticle surface such that the brain injury site-targeted peptides do not spatially mask each other, and wherein the biocompatible flexible liposome nanoparticle shape, size and elastic modulus facilitates margination to a vascular wall and their bio-interactions upon administration to a vasculature of the subject.
Dependencies are inferred from the claim text.